相关实验视频
Updated: Jun 23, 2025

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.6K
以15-氧基酶为媒介的脂质过氧化调节LRRK2激酶活性
bioRxiv : the preprint server for biology
|June 25, 2024
概括
研究人员发现,4-hydroxynonenal (4-HNE) 激活了帕金森氏症中富含白素的重复激酶2 (LRRK2).
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 的突变与遗传性帕金森病 (PD) 有关.
- 野生型 (WT) LRRK2激酶活性在异常性PD (iPD) 中升高,但其调节不清楚.
- 像线粒体功能障碍这样的压力因素会激活WT LRRK2,但机制仍然难以捉摸.
研究的目的:
- 阐明调节内源性WT LRRK2激酶活性的分子机制.
- 为了确定LRRK2过活化的上游调节者在异常病性PD.
- 探索帕金森病的新型治疗点.
主要方法:
- 研究了4-hydroxynonenal (4-HNE) 在LRRK2调节中的作用.
- 使用生物化学分析来检测LRRK2.2上的4-HNE添加物.
- 采用了15-氧基酶 (15-LO) 抑制和基因剥离模型.
主要成果:
- 4-hydroxynonenal (4-HNE) 是对激活LRRK2的刺激的一个常见反应.
- 在LRRK2中,4-HNE与Cys2024/Cys2025形成 adducts,增加了激酶活性.
- 15-氧基酶 (15-LO) 产生调节LRRK2.2.的4-HNE.
结论:
- 15-氧基酶 (15-LO) 是致病性LRRK2过活化的上游调节剂.
- 抑制15-LO或向LRRK2Cys2024/2025提供了潜在的PD治疗策略.
- 降低4-HNE水平可能会调节用于PD治疗的LRRK2活性.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Peroxisomes
12.0K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.0K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K

